As we recognize Juneteenth and reflect on the ongoing pursuit of equity, representation, and opportunity, it is also an important moment to consider where those principles intersect with healthcare and clinical research. This week, PEP!IN hosted a special episode of Trial & Error: New Focus on Triple Negative Breast Cancer Research – Reaching the Right Patients. The conversation featured Dr. Cheryl Beal Anderson, Founder and CEO of ACE Regulatory Affairs Consulting; Dr. Melva

I've spent the last several weeks helping prepare for a conversation we're hosting on Triple Negative Breast Cancer (TNBC) research and reaching the right patients for research studies. Like many people, I started where most of us start, I began reading. I wanted to better understand TNBC, the patients most impacted by it, and the realities surrounding the disease. As I dug into the data, I found what many researchers, healthcare professionals, and patient advocates already k

Women’s History Month always makes me pause. It’s a time to reflect on progress. The doors opened, the barriers challenged, the milestones achieved. But for me, it’s also a time to think about something just as important: who is shaping what comes next. Last week, we premiered the first conversation in our Trial & Error series, “Designing Clinical Trials that Work.” As I sat in that conversation, I found myself reflecting on something I see every day in this work. Clinical